Robert E. Landry, EVP Finance CFO at REGENERON PHARMACEUTICALS, INC. (REGN), sold 1,392 shares at $654.46 ($911K) on 2020-08-04, disclosed to the SEC on 2020-08-05.
Open-market sale of $911k REGN by EVP Finance CFO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $654.46 | 696 | $456K | 50.0% |
| 2 | $654.46 | 696 | $456K | 50.0% |
| Total | $654.46 avg | 1,392 | $911K | 100% |
| Filing → |
| REGN | SELL | 2023-08-25 | $188K | — | Filing → |
| REGN | SELL | 2023-03-29 | $1.8M | — | Filing → |
| REGN | SELL | 2023-02-07 | $2.1M | — | Filing → |